National Comprehensive Cancer Network

Educational Events & Programs

NCCN 5^th Annual Congress: Hematologic Malignancies™

Supporting Organizations

The educational portion of this congress is supported by educational grants from:

• Allos Therapeutics, Inc.
• ARIAD Pharmaceuticals
• Bristol-Myers Squibb
• Celgene Corporation
• Centocor Ortho Biotech
• Eisai Inc.
• Genentech BioOncology and Biogen Idec
• Merck
• Millennium Pharmaceuticals, Inc.
• Novartis Oncology
• Otsuka America Pharmaceutical, Inc.
• Pfizer
• sanofi-aventis
• Sigma-Tau Pharmaceuticals, Inc.

This activity is supported by an educational donation provided by:

• Amgen

Support was solicited from a broad array of managed care and pharma/biotech companies and organizations. This list will be updated as additional supporters are confirmed.

The National Comprehensive Cancer Network® (NCCN®) appreciates that supporting companies recognize NCCN®’s need for autonomy in the development of the content of NCCN® resources. All NCCN Content is produced completely independently.